Comparative study between cytology and dot-ELISA for early detection of bladder cancer

American Journal of Clinical Pathology

Volumn 105, Issue 1, 1996, Pages 109-114

  Attallah, A M ^a   El Didi, M ^b   Seif, F ^b   El Mohamady, H ^b   Dalbagni, G ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b NONE

Author keywords

Bladder cancer cytology; Cytokeratin; Dot ELISA; MoAb; Urine

Indexed keywords

ADENOCARCINOMA; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER CYTODIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHISTOSOMIASIS; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY;

EID: 0030064445     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.1.109     Document Type: Article

References (21)

1. El Bolkainy MN, Chu EW. Detection of bladder cancer associated with schistosomiasis. National Cancer Institute, Al-Ahram Press, 1981, p 112.
2. Kohler G, Milstein C. Continuous culture of fused cells secreting antibodies of predefined specificity. Nature 1975;256:495-497.
3. Pamela JR, Jane P, Raghavan D. The use of monoclonal antibodies for the diagnosis and therapy of bladder cancer. Br J Urol 1993;71:121-129.
4. Moll R, Achstatter T, Becht E. Cytokeratins in normal and malignant transitional epithelium. Am J Pathol 1988;132:123-144.
5. Liu BCS, Neuwirth H, Zhu LW. Detection of once fetal bladder antigen in urine of patients with transitional cell carcinomos. J Urol 1987;137:1258-1261.
6. Masuko T, Sugahara K, Kamiya. Increase in murine monoclonal-antibody-defined urinary antigens in patients with bladder cancer and benign urogenital disease. Int J Cancer 1989;44:582-588.
7. Attallah AM, Helmi H, El-Helali E, et al. A dipstick Dot ELISA assay for the rapid and early detection of bladder cancer. J Cancer Detection and Prevention 1991;15:495-499.
8. Koss LG. Diagnostic cytology and its histopathologic bases. In: Philadelphia: JB Lippincott, 1979.
9. El-Bolkainy MN. Cytology of bladder carcinoma. J Urol 1980;124:20-22.
10. King EB. Cytology of bladder cancer. In: Bryan GT, Cohen SM, eds. The Pathology of Bladder Cancer. Boca Raton, FL: CRC Press, 1983.
11. Pearson JC, Kromhout L, King EB. Evaluation of collection and preservation techniques of urinary cytology. Acta Cytol 1981;25:327-333.
12. Muphy WM, Soloway, MS, Jukkola AF. Urinary cytology and bladder cancer: The cellular features of transitional cell neoplasms. Cancer 1984;53:1555-1559.
13. Bales CE. A semi-automated method for preparation of urine sediment for cytologic evaluation. Acta Cytol 1981;25:323-326.
14. Beyer-Boon ME, Hollander NJ. Cell yield obtained with various cytopreparatory techniques of urine cytology. Acta Cytol 1978;22:589-593.
15. Friedell CH, Soto GA, Nagy GK. Cytologic and histopathologic studies of bladder cancer patients. Urol Clin North Am 1976;3: 71-78.
16. Badalament RA, Fair WA, Whitmore WF. The relative value of cytometry and cytology in the management of bladder cancer: The Memorial Sloan-Kettering Cancer Center experience. Semin Urol 1988;6:29.
17. Baker WMC, Devere White R, Rossitto P. Quantitative analysis of keratin 18 in the urine of patients with bladder cancer. J Urol 1988;140:436-439.
18. Martin J. Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol 1989;42:250-256.
19. Benson R, Swanson S, Farrow G. Relationship of leukoplakia to urothelial malignancy. J Urol 1984;131:507-511.
20. Rossitto PV, Chan R, Strand MA. Characterization of urinary keratin number 18 using a new assay. J Urol 1988;140:431-435.
21. Beyer-Boon ME, Cuypers LHRI, de Voogt. Cytological changes due to urinary calculi. Br J Urol 1978;50:81-89.